Mergers & Acquisitions ·
Indivior Pharmaceuticals declared a special cash dividend of $8.13 per share for common stockholders and holders of…
INDVSupernus, Inc.
Indivior Pharmaceuticals declared a special cash dividend of $8.13 per share for common stockholders and holders of certain equity awards, contingent upon the closing of its merger with Supernus Pharmaceuticals. The record date is October 30, 2026, with payment anticipated on or about November 6, 2026, assuming the merger closes around November 2, 2026. Indivior operates in the pharmaceutical industry, specializing in long-acting injectable treatments for opioid use disorder.